BOSELLI, Maria Linda
 Distribuzione geografica
Continente #
NA - Nord America 1.518
EU - Europa 1.496
AS - Asia 553
AF - Africa 15
OC - Oceania 4
SA - Sud America 4
Totale 3.590
Nazione #
US - Stati Uniti d'America 1.503
GB - Regno Unito 805
CN - Cina 302
IT - Italia 133
SE - Svezia 130
SG - Singapore 128
IE - Irlanda 81
FR - Francia 77
FI - Finlandia 76
RU - Federazione Russa 71
DE - Germania 59
KR - Corea 38
PK - Pakistan 20
IN - India 19
BE - Belgio 16
UA - Ucraina 16
AT - Austria 8
CA - Canada 8
GR - Grecia 8
VN - Vietnam 8
HK - Hong Kong 7
ID - Indonesia 7
GH - Ghana 6
JP - Giappone 6
NL - Olanda 6
TR - Turchia 6
BD - Bangladesh 4
BR - Brasile 3
CR - Costa Rica 3
AU - Australia 2
EG - Egitto 2
IR - Iran 2
NZ - Nuova Zelanda 2
PL - Polonia 2
ZA - Sudafrica 2
AM - Armenia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 3.590
Città #
Southend 775
Ashburn 371
Chandler 242
Ann Arbor 125
Singapore 100
Jacksonville 99
Woodbridge 91
Beijing 83
Dublin 81
Houston 75
New York 72
Verona 65
Helsinki 31
Lawrence 31
Princeton 31
Wilmington 31
Seoul 26
Jinan 25
Shenyang 20
Nanjing 19
Boardman 17
Mianwali 17
Brussels 16
Redmond 15
Santa Clara 13
Hyderabad 11
Hebei 10
Los Angeles 10
Sindelfingen 10
Washington 10
Dearborn 9
Romola 9
Tianjin 9
Changsha 8
Hangzhou 8
Nikaia 8
Vienna 8
Hong Kong 7
Nanchang 7
Zhengzhou 7
Accra 6
Dallas 6
Haikou 6
Kent 6
Malda 6
Cagliari 5
Dong Ket 5
Taiyuan 5
Taizhou 5
Dhaka 4
Guangzhou 4
Jakarta 4
Jiaxing 4
Milan 4
Seattle 4
Yongin-si 4
Auburn Hills 3
Bologna 3
Denpasar 3
Frankfurt am Main 3
Kitchener 3
Moscow 3
Ningbo 3
Norwalk 3
Redwood City 3
San Francisco 3
San José 3
Tokyo 3
Auckland 2
Baltimore 2
Berea 2
Cairo 2
Catanzaro 2
Chicago 2
Clearwater 2
Columbus 2
Coventry 2
Dongguan 2
Espoo 2
Essen 2
Fuzhou 2
Groningen 2
Incheon 2
Istanbul 2
Kharkov 2
Lancaster 2
London 2
Phoenix 2
Richmond 2
Riva 2
San Pedro 2
Stockholm 2
Tehran 2
Toronto 2
Trento 2
Amsterdam 1
Atlanta 1
Bangkok 1
Bishkek 1
Boston 1
Totale 2.775
Nome #
American Diabetes Association 75th Scientific Meeting - Epidemiology/Genetics Section; Poster 1563-P: Pancreatic Beta-Cell Function, Insulin Sensitivity, and Metabolic Phenotypes in Type 2 Diabetes at the Time of Diagnosis—The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 643
Common Variants Associated to Type 2 Diabetes in the Italian Population 377
"Presence and titer of GAD antibodies are determinants of beta cell function in patients with newly diagnosed type 2 diabetes mellitus: further insights in the metabolic phenotype of LADA patients" 134
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 132
PPARG2 Pro12Ala and ADAMTS9 rs4607103 as "insulin resistance loci" and "insulin secretion loci" in Italian individuals. The GENFIEV study and the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 4. 118
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 113
Variants and haplotypes of TCF7L2 are associated with beta cell function in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS).1. 107
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 105
Relationship of Chronic Vascular Complications with Beta-Cell Dysfunction and Insulin Resistance in Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 98
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 96
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 95
“Genetic Load” of diabetes risk alleles affects beta-cell function in patients with newly diagnosed type 2 diabetes 95
A parsimonious model of a mixed-meal test in patients with type 1 diabetes in insulin pump therapy 94
Is common genetic variation at IRS1, ENPP1 and TRIB3 loci associated with cardiometabolic phenotypes in type 2 diabetes? An exploratory analysis of the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 5 94
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 91
A low "genetic load" of risk variants for type 2 diabetes is associated to better beta cell function in patients with newly diagnosed type 2 diabetes 87
In patients with newly-diagnosed type 2 diabetes beta cell function is an independent predictor of glucose control evolution over 18 months 87
Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6 86
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 80
Quantitation of the roles played by the main determinants of meal glucose tolerance in patients with type 1 diabetes on insulin pump therapy 80
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 76
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease 76
Type 2 Diabetes Mellitus: a Disease of the Governance of the Glucose-Insulin System. An Experimental Metabolic Control Analysis Study. 74
A renal genetic risk score (GRS) is associated with kidney dysfunction in people with type 2 diabetes 74
Defects in the dynamic control of beta cell function and in glucose effectiveness underly the initial decline in intravenous glucose tolerance of obese European children 73
Uric acid is a biomarker of beta cell function in patients with newly diagnosed type 2 diabetes 70
“IGT-like” status in normoglucose tolerant obese children and adolescents: the additive role of glucose profile morphology and 2-hours glucose concentration during the oral glucose tolerance test 70
Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11) 67
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 56
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients 55
Methods to assess in vivo insulin sensitivity and insulin secretion 53
Changes induced by metabolic surgery on the main components of glucose/insulin system in patients with diabetes and obesity 35
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 34
Crosstalk between genetic variability of adiponectin and leptin, glucose‐insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14 18
A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass 14
Interactions of the Osteokines, Glucose/Insulin System and Vascular Risk Networks in Patients With Newly Diagnosed Type 2 Diabetes (VNDS 15) 11
Insulin resistance and beta‐cell dysfunction in newly diagnosed type 2 diabetes: Expression, aggregation and predominance. Verona Newly Diagnosed Type 2 Diabetes Study 10 5
Totale 3.673
Categoria #
all - tutte 10.840
article - articoli 5.513
book - libri 0
conference - conferenze 5.117
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 210
Totale 21.680


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020333 0 0 0 0 49 54 41 23 20 54 43 49
2020/2021370 21 61 25 33 43 36 16 19 30 20 31 35
2021/2022309 51 69 18 44 12 8 4 14 8 6 14 61
2022/2023624 47 88 51 116 52 139 12 31 62 7 14 5
2023/2024768 13 24 37 46 50 129 10 281 6 72 73 27
2024/2025383 35 64 45 209 30 0 0 0 0 0 0 0
Totale 3.673